未登录 分享 收藏
Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats Nicklas, Paige R.; Kiefer, Miranda L.; Whalen, Mikaela A.; Stewart, Maeve T.; Mosura, Deandra E.; Bennett, Elizabeth M.; Hawley, Wayne R.; McLaughlin, Peter J. 分享 收藏
分享 收藏
分享 收藏
Phase 2 Trial of Bortezomib in Combination With Rituximab Plus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Alternating With Bortezomib, Rituximab, Methotrexate, and Cytarabine for Untreated Mantle Cell Lymphoma Romaguera, Jorge E.; Wang, Michael; Feng, Lei; Fayad, Luis E.; Hagemeister, Frederick; McLaughlin, Peter; Rodriguez, M. Alma; Fanale, Michelle; Orlowski, Robert; Kwak, Larry W.; Neelapu, Sattva; Oki, Yasuhiro; Pro, Barbara; Younes, Anas; Samaniego, Felipe; Fowler, Nathan; Hartig, Kimberly; Valentinetti, Marisa; Smith, Judy; Ford, Peggy; Naig, Adam; Medeiros, L. Jeffrey; Kantarjian, Hagop M.; Goy, Andre 分享 收藏
Impact of the Timing of Hepatitis B Virus Identification and Anti-Hepatitis B Virus Therapy Initiation on the Risk of Adverse Liver Outcomes for Patients Receiving Cancer Therapy Hwang, Jessica P.; Suarez-Almazor, Maria E.; Cantor, Scott B.; Barbo, Andrea; Lin, Heather Y.; Ahmed, Sairah; Chavez-MacGregor, Mariana; Donato-Santana, Christian; Eng, Cathy; Ferrajoli, Alessandra; Fisch, Michael J.; McLaughlin, Peter; Simon, George R.; Rondon, Gabriela; Shpall, Elizabeth J.; Lok, Anna S. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma Esmaeli, B.; McLaughlin, P.; Pro, B.; Samaniego, F.; Gayed, I.; Hagemeister, F.; Romaguera, J.; Cabanillas, F.; Neelapu, S. S.; Banay, R.; Fayad, L.; Saville, M. Wayne; Kwak, L. W. 分享 收藏
Phase 2 Trial of Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus Methotrexate-Cytarabine for Relapsed or Refractory Aggressive Mantle Cell Lymphoma Wang, Michael; Fayad, Luis; Cabanillas, Fernando; Hagerneister, Fredrick; McLaughlin, Peter; Rodriguez, Maria A.; Kwak, Larry W.; Zhou, Yuhong; Kantarjian, Hagop; Romaguera, Jorge 分享 收藏
The novel cannabinoid CB1 receptor neutral antagonist Am4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats (vol 33, pg 946, 2008) Sink, Kelly S.; McLaughlin, Peter J.; Wood, Jodi Anne T.; Brown, Cara; Fan, Pusheng; Vemuri, V. Kiran; Pang, Yan; Olzewska, Teresa; Thakur, Ganesh A.; Makriyannis, Alex; Parker, Linda A.; Salamone, John D. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma CHOP化疗加用利妥昔单抗可改善滤泡3级淋巴瘤的总体和无失败生存率 Overman, M. J.; Feng, L.; Pro, B.; McLaughlin, P.; Hess, M.; Samaniego, F.; Younes, A.; Romaguera, J. E.; Hagemeister, F. B.; Kwak, L.; Cabanillas, F.; Rodriguez, M. A.; Fayad, L. E. 分享 收藏
分享 收藏
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma 吉西他滨联合利妥昔单抗治疗复发或难治性霍奇金淋巴瘤的2期研究 Oki, Yasuhiro; Pro, Barbara; Fayad, Luis E.; Rornaguera, Jorge; Sarnaniego, Felipe; Fredrick, Hagerneister; Neelapu, Sattva; McLaughlin, Peter; Goy, Andre; Younes, Anas 分享 收藏
分享 收藏